Treatment of radiation-induced myelopathy with bevacizumab

Clin Transl Oncol. 2020 Jun;22(6):957-960. doi: 10.1007/s12094-019-02209-5. Epub 2019 Sep 21.
No abstract available

Keywords: Bevacizumab; Radiation-induced myelopathy; Radionecrosis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Angiogenesis Inhibitors / administration & dosage*
  • Antineoplastic Agents, Immunological / administration & dosage*
  • Astrocytoma / radiotherapy
  • Bevacizumab / administration & dosage*
  • Child
  • Female
  • Humans
  • Necrosis
  • Radiation Injuries / drug therapy*
  • Radiation Injuries / pathology
  • Radiotherapy, Intensity-Modulated / adverse effects
  • Spinal Cord / drug effects*
  • Spinal Cord / pathology
  • Spinal Neoplasms / radiotherapy
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Angiogenesis Inhibitors
  • Antineoplastic Agents, Immunological
  • Bevacizumab